Checkpoint Therapeutics Inc (NASDAQ:CKPT)

BATS BZX Real-Time Price
As of 1:04pm ET
 +0.04 / +0.72%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Checkpoint Therapeutics Inc have a median target of 41.00, with a high estimate of 96.00 and a low estimate of 15.00. The median estimate represents a +634.77% increase from the last price of 5.58.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Checkpoint Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.69%
Growthannually 36.49%


Growthquarterly -16.67%
Growthannually -45.07%
Key to the earnings and sales forecast charts.